The state of Illinois currently has 25 active clinical trials seeking participants for Multiple Sclerosis research studies. These trials are conducted in various cities, including Chicago, Peoria, Springfield and Urbana.
Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
Recruiting
Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Relapsing Multiple Sclerosis (ENSURE-1)
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
04/17/2024
Locations: Consultants in Neurology, Ltd, Northbrook, Illinois
Conditions: Multiple Sclerosis